CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.

Oncology
Reviewed By
Martin graduated from the University of Newcastle upon Tyne and gained general medical experience in New Zealand, Australia, and the United Kingdom, becoming a member of the Royal College of Physicians (UK) in 2000. He has been working in cancer care since then, training in Medical Oncology at the Oxford Radcliffe and Royal Marsden Trusts. During this time, he achieved a PhD at the Institute for Cancer Research, London, and was awarded the EORTC-PAMM Young Investigator Award in 2004. He completed his specialist training in Medical Oncology in 2008 and was appointed as a Clinical Senior Lecturer and Consultant in Medical Oncology in 2009. Martin manages patients with lung and head and neck cancers, with a particular interest in drug development and using cancer biology to design studies for new drugs and combinations. His areas of expertise include chemotherapy, lung and head and neck cancers, drug development, and cancer biology.
It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.
Clinical Oncology, Medical Oncology
English
MBBS, FRCP, PhD
General Medical Council: 4129392
5th Floor UCH Macmillan Cancer Centre, Huntley Street, London, WC1E 6AG
Unavailable
New appointment: £300
Follow-up appointment: £250
Reviewed By